559 related articles for article (PubMed ID: 16736384)
21. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility.
Maccarrone M; Valensise H; Bari M; Lazzarin N; Romanini C; Finazzi-Agrò A
J Immunol; 2001 Jun; 166(12):7183-9. PubMed ID: 11390466
[TBL] [Abstract][Full Text] [Related]
22. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
23. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
24. Anandamide transport: a critical review.
Glaser ST; Kaczocha M; Deutsch DG
Life Sci; 2005 Aug; 77(14):1584-604. PubMed ID: 15979096
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
Mulder AM; Cravatt BF
Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
[TBL] [Abstract][Full Text] [Related]
27. The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.
Alexander JP; Cravatt BF
J Am Chem Soc; 2006 Aug; 128(30):9699-704. PubMed ID: 16866524
[TBL] [Abstract][Full Text] [Related]
28. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
Kaczocha M; Hermann A; Glaser ST; Bojesen IN; Deutsch DG
J Biol Chem; 2006 Apr; 281(14):9066-75. PubMed ID: 16461355
[TBL] [Abstract][Full Text] [Related]
29. Role of FAAH-like anandamide transporter in anandamide inactivation.
Leung K; Elmes MW; Glaser ST; Deutsch DG; Kaczocha M
PLoS One; 2013; 8(11):e79355. PubMed ID: 24223930
[TBL] [Abstract][Full Text] [Related]
30. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.
Patel S; Wohlfeil ER; Rademacher DJ; Carrier EJ; Perry LJ; Kundu A; Falck JR; Nithipatikom K; Campbell WB; Hillard CJ
Br J Pharmacol; 2003 Jul; 139(5):1005-13. PubMed ID: 12839875
[TBL] [Abstract][Full Text] [Related]
31. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
Thors L; Eriksson J; Fowler CJ
Br J Pharmacol; 2007 Nov; 152(5):744-50. PubMed ID: 17676056
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
Glaser ST; Gatley SJ; Gifford AN
J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
[TBL] [Abstract][Full Text] [Related]
35. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
36. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
37. A catalytically silent FAAH-1 variant drives anandamide transport in neurons.
Fu J; Bottegoni G; Sasso O; Bertorelli R; Rocchia W; Masetti M; Guijarro A; Lodola A; Armirotti A; Garau G; Bandiera T; Reggiani A; Mor M; Cavalli A; Piomelli D
Nat Neurosci; 2011 Nov; 15(1):64-9. PubMed ID: 22101642
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
39. Identification of intracellular carriers for the endocannabinoid anandamide.
Kaczocha M; Glaser ST; Deutsch DG
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6375-80. PubMed ID: 19307565
[TBL] [Abstract][Full Text] [Related]
40. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
